SmartLabs, a First-of-Its-Kind Laboratory-as-a-Service, Expands Nationally with CA Location SmartLabs announces a national expansion with the addition of 80,000 sq. feet in South San Francisco, California and $36 million in Series A funding. Read More
Gritstone Oncology Doses First Patient with SLATE SmartLabs' Member Company Gritstone Oncology dosed its first patient an investigational immunotherapy directed at shared tumor-specific neoantigens. Read More
Gritstone Oncology Reports 2Q 2019 Earnings SmartLabs' Member Company Gritstone Oncology has advanced two candidates into clinical development since its IPO last September. Read More
Kronos Bio raises $105 Million in Series A Financing SmartLabs' Member Company Kronos Bio brought in $105 million in venture investment through a financing round led by Vida Ventures and Omega Funds. Read More
Gritstone Oncology Hires EVP of Manufacturing and Technical Operations SmartLabs Member Company Gritstone Oncology has brought on industry veteran Vijay Yabannavar, Ph.D., as executive vice president of manufacturing and technical operations. Read More
Entering New Industries Requires Finding Creative Solutions Nikon Instruments became a part of the SmartLabs community in Cambridge in order to test out a new imaging service it has been developing for regenerative medicine clients. Read More
Promising Technology Needs the Space to Grow Traditional real estate doesn't allow early biotechs to grow rapidly and unexpectedly as the science progresses. Cue Biopharma found the solution to this challenge by joining SmartLabs. Read More
Interview: How to Jump Five Unforeseen Hurdles to Biotech Success Ahead of the Biotechnology Innovation Organization (BIO)’s annual conference, SmartLabs' Lisa LaMotta sat down with Partnering Insight to talk about some of the challenges entrepreneurs face when trying to start a company. Read More
Gritstone Oncology to Host Key Opinion Leader Discussion at ASCO SmartLabs Member Company Gritstone Oncology will webcast an event with key opinion leaders who will present on neoantigen-based immunotherapy on Monday, June 3, 2019 from 6:30-8:00 a.m. CT in Chicago. Read More
Cue Biopharma Receives FDA Acceptance of IND SmartLabs Member Company Cue Biopharma will begin human clinical testing of its lead drug candidate CUE-101, making the biotech a development-stage company. Read More
Gritstone Oncology Reports First Quarter Highlights SmartLabs Member Company Gritstone expects to submit an Investigational New Drug application for the Phase 1/2 study of SLATE-001 in the second quarter of 2019 Read More
